F-arag f-18 clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses f-arag f-18 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
Lawrence Fong (1) · University of Tennessee (1) · University of California, Davis (1) · University of California, San Francisco (1)
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses f-arag f-18 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung CancerStatus unknownPhase 1University of TennesseeNCT04052412Written as 18F-AraG
- [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyWithdrawnEarly Phase 1University of California, DavisNCT04186988Written as Fluorine F 18 Ara-G
- Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1TerminatedPhase 2Lawrence FongNCT03007719Written as Fluorine F 18 Ara-G
- T-Cell PET Imaging With [18F]F-AraG in Lung CancerWithdrawnPhase 2University of California, San FranciscoNCT03311672Written as [18F]F-Ara-G
Codes
What other systems call f-arag f-18 · ClinicalTrials.gg INT018448
- UNII (FDA) X96PT3B08GF-ARAG F-18Confirmed FDA, Wikidata
- Wikidata Q27895879f-arag f-18Confirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | X96PT3B08G | F-ARAG F-18 | Confirmed FDA, Wikidata |
| Wikidata | Q27895879 | f-arag f-18 | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.